Annual D&A
$76.20 K
-$69.20 K-47.59%
31 August 2024
Summary:
Lexaria Bioscience annual depreciation & amortization is currently $76.20 thousand, with the most recent change of -$69.20 thousand (-47.59%) on 31 August 2024. During the last 3 years, it has fallen by -$71.40 thousand (-48.37%). LEXX annual D&A is now -83.18% below its all-time high of $453.10 thousand, reached on 31 October 2008.LEXX Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
-$7800.00
-$47.00 K-119.90%
31 August 2024
Summary:
Lexaria Bioscience quarterly depreciation & amortization is currently -$7800.00, with the most recent change of -$47.00 thousand (-119.90%) on 31 August 2024. Over the past year, it has dropped by -$36.60 thousand (-127.08%). LEXX quarterly D&A is now -103.89% below its all-time high of $200.70 thousand, reached on 30 April 2009.LEXX Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$76.10 K
-$78.70 K-50.84%
31 August 2024
Summary:
Lexaria Bioscience TTM depreciation & amortization is currently $76.10 thousand, with the most recent change of -$78.70 thousand (-50.84%) on 31 August 2024. Over the past year, it has dropped by -$73.30 thousand (-49.06%). LEXX TTM D&A is now -84.41% below its all-time high of $488.10 thousand, reached on 31 July 2008.LEXX TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LEXX Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -47.6% | -127.1% | -49.1% |
| 3 y3 years | -48.4% | -128.0% | -48.4% |
| 5 y5 years | +25.9% | -128.4% | -12.0% |
LEXX Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -48.4% | at low | -111.0% | at low | -50.8% | at low |
| 5 y | 5 years | -48.4% | +25.9% | -111.0% | at low | -50.8% | at low |
| alltime | all time | -83.2% | >+9999.0% | -103.9% | +96.1% | -84.4% | +138.2% |
Lexaria Bioscience Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Aug 2024 | $76.20 K(-47.6%) | -$7800.00(-119.9%) | $76.10 K(-50.8%) |
| May 2024 | - | $39.20 K(+146.5%) | $154.80 K(+10.1%) |
| Feb 2024 | - | $15.90 K(-44.8%) | $140.60 K(-5.9%) |
| Nov 2023 | - | $28.80 K(-59.4%) | $149.40 K(+2.8%) |
| Aug 2023 | $145.40 K(+41.6%) | $70.90 K(+183.6%) | $145.30 K(+46.6%) |
| May 2023 | - | $25.00 K(+1.2%) | $99.10 K(+1.1%) |
| Feb 2023 | - | $24.70 K(0.0%) | $98.00 K(-1.5%) |
| Nov 2022 | - | $24.70 K(0.0%) | $99.50 K(-3.1%) |
| Aug 2022 | $102.70 K(-30.4%) | $24.70 K(+3.3%) | $102.70 K(-27.6%) |
| May 2022 | - | $23.90 K(-8.8%) | $141.80 K(-2.7%) |
| Feb 2022 | - | $26.20 K(-6.1%) | $145.80 K(-1.2%) |
| Nov 2021 | - | $27.90 K(-56.3%) | $147.50 K(0.0%) |
| Aug 2021 | $147.60 K(+1.0%) | $63.80 K(+128.7%) | $147.50 K(+1.1%) |
| May 2021 | - | $27.90 K(0.0%) | $145.90 K(-0.1%) |
| Feb 2021 | - | $27.90 K(0.0%) | $146.10 K(-0.3%) |
| Nov 2020 | - | $27.90 K(-55.1%) | $146.50 K(+0.3%) |
| Aug 2020 | $146.10 K(+141.5%) | $62.20 K(+121.4%) | $146.10 K(+32.7%) |
| May 2020 | - | $28.10 K(-0.7%) | $110.10 K(+5.2%) |
| Feb 2020 | - | $28.30 K(+2.9%) | $104.70 K(+21.0%) |
| Nov 2019 | - | $27.50 K(+5.0%) | $86.50 K(+42.7%) |
| Aug 2019 | $60.50 K(+2530.4%) | $26.20 K(+15.4%) | $60.60 K(+71.7%) |
| May 2019 | - | $22.70 K(+124.8%) | $35.30 K(+169.5%) |
| Feb 2019 | - | $10.10 K(+531.3%) | $13.10 K(+274.3%) |
| Nov 2018 | - | $1600.00(+77.8%) | $3500.00(+52.2%) |
| Aug 2018 | $2300.00(+53.3%) | $900.00(+80.0%) | $2300.00(+27.8%) |
| May 2018 | - | $500.00(0.0%) | $1800.00(+5.9%) |
| Feb 2018 | - | $500.00(+25.0%) | $1700.00(+6.3%) |
| Nov 2017 | - | $400.00(0.0%) | $1600.00(0.0%) |
| Aug 2017 | $1500.00 | $400.00(0.0%) | $1600.00(+14.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| May 2017 | - | $400.00(0.0%) | $1400.00(+16.7%) |
| Feb 2017 | - | $400.00(0.0%) | $1200.00(+20.0%) |
| Nov 2016 | - | $400.00(+100.0%) | $1000.00(+25.0%) |
| Aug 2016 | $600.00(+50.0%) | $200.00(0.0%) | $800.00(+33.3%) |
| May 2016 | - | $200.00(0.0%) | $600.00(+50.0%) |
| Feb 2016 | - | $200.00(0.0%) | $400.00(+100.0%) |
| Nov 2015 | - | $200.00(>+9900.0%) | $200.00(-60.0%) |
| Oct 2011 | $400.00(-60.0%) | $0.00(0.0%) | $500.00(-37.5%) |
| July 2011 | - | $0.00(-100.0%) | $800.00(-27.3%) |
| Apr 2011 | - | $200.00(-33.3%) | $1100.00(-8.3%) |
| Jan 2011 | - | $300.00(0.0%) | $1200.00(0.0%) |
| Oct 2010 | $1000.00(-23.1%) | $300.00(0.0%) | $1200.00(0.0%) |
| July 2010 | - | $300.00(0.0%) | $1200.00(-100.6%) |
| Apr 2010 | - | $300.00(0.0%) | -$199.20 K(<-9900.0%) |
| Jan 2010 | - | $300.00(0.0%) | $1200.00(-7.7%) |
| Oct 2009 | $1300.00(-99.7%) | $300.00(-100.1%) | $1300.00(-98.9%) |
| July 2009 | - | -$200.10 K(-199.7%) | $114.70 K(-71.3%) |
| Apr 2009 | - | $200.70 K(>+9900.0%) | $399.80 K(+27.7%) |
| Jan 2009 | - | $400.00(-99.6%) | $313.10 K(-30.9%) |
| Oct 2008 | $453.10 K(+205.3%) | $113.70 K(+33.8%) | $453.10 K(-7.2%) |
| July 2008 | - | $85.00 K(-25.4%) | $488.10 K(+21.0%) |
| Apr 2008 | - | $114.00 K(-18.8%) | $403.30 K(+140.6%) |
| Jan 2008 | - | $140.40 K(-5.6%) | $167.60 K(+12.9%) |
| Oct 2007 | $148.40 K(+81.4%) | $148.70 K(>+9900.0%) | $148.40 K(+82.8%) |
| July 2007 | - | $200.00(-100.2%) | $81.20 K(0.0%) |
| Apr 2007 | - | -$121.70 K(-200.4%) | $81.20 K(-60.0%) |
| Jan 2007 | - | $121.20 K(+48.7%) | $203.00 K(+148.2%) |
| Oct 2006 | $81.80 K | $81.50 K(>+9900.0%) | $81.80 K(>+9900.0%) |
| July 2006 | - | $200.00(+100.0%) | $300.00(+200.0%) |
| Apr 2006 | - | $100.00 | $100.00 |
FAQ
- What is Lexaria Bioscience annual depreciation & amortization?
- What is the all time high annual D&A for Lexaria Bioscience?
- What is Lexaria Bioscience annual D&A year-on-year change?
- What is Lexaria Bioscience quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Lexaria Bioscience?
- What is Lexaria Bioscience quarterly D&A year-on-year change?
- What is Lexaria Bioscience TTM depreciation & amortization?
- What is the all time high TTM D&A for Lexaria Bioscience?
- What is Lexaria Bioscience TTM D&A year-on-year change?
What is Lexaria Bioscience annual depreciation & amortization?
The current annual D&A of LEXX is $76.20 K
What is the all time high annual D&A for Lexaria Bioscience?
Lexaria Bioscience all-time high annual depreciation & amortization is $453.10 K
What is Lexaria Bioscience annual D&A year-on-year change?
Over the past year, LEXX annual depreciation & amortization has changed by -$69.20 K (-47.59%)
What is Lexaria Bioscience quarterly depreciation & amortization?
The current quarterly D&A of LEXX is -$7800.00
What is the all time high quarterly D&A for Lexaria Bioscience?
Lexaria Bioscience all-time high quarterly depreciation & amortization is $200.70 K
What is Lexaria Bioscience quarterly D&A year-on-year change?
Over the past year, LEXX quarterly depreciation & amortization has changed by -$36.60 K (-127.08%)
What is Lexaria Bioscience TTM depreciation & amortization?
The current TTM D&A of LEXX is $76.10 K
What is the all time high TTM D&A for Lexaria Bioscience?
Lexaria Bioscience all-time high TTM depreciation & amortization is $488.10 K
What is Lexaria Bioscience TTM D&A year-on-year change?
Over the past year, LEXX TTM depreciation & amortization has changed by -$73.30 K (-49.06%)